Home/Filings/4/0001144204-13-033217
4//SEC Filing

BAXANO SURGICAL, INC. 4

Accession 0001144204-13-033217

CIK 0001230355operating

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:25 PM ET

Size

9.7 KB

Accession

0001144204-13-033217

Insider Transaction Report

Form 4
Period: 2013-05-31
HIRSCH RUSSELL C
Director10% Owner
Transactions
  • Other

    Common Stock

    2013-05-31+3,330,8105,340,616 total(indirect: Prospect Venture Partners III, L.P.)
  • Purchase

    Common Stock

    2013-05-31$2.28/sh+2,009,806$4,582,3582,009,806 total(indirect: Prospect Venture Partners III, L.P.)
  • Award

    Stock Option (right to buy)

    2013-05-31+30,00030,000 total
    Exercise: $2.06Exp: 2023-05-30Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]The reportable securities are owned directly by Prospect Venture Partners III, L.P. Dr. Hirsch is a Managing Director of Prospect Venture Partners III, L.P., and has shared voting and dispositive power with respect to the shares held by Prospect Venture Partners III, L.P. Dr. Hirsch disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
  • [F2]Received in exchange for outstanding convertible promissory notes and shares of Series C Preferred Stock of Baxano, Inc. pursuant to the Agreement and Plan of Merger, dated March 3, 2013, by and among TranS1 Inc. (now Baxano Surgical, Inc.), RacerX Acquisition Corp., Baxano, Inc., and Sumeet Jain and David Schulte as Securityholder Representatives, as amended by the First Amendment to Agreement and Plan of Merger, dated April 10, 2013, by and among the parties.
  • [F3]25% of the stock option shall vest on May 31, 2014 and the remaining 75% of the stock option shall vest thereafter in 36 equal monthly installments.

Issuer

BAXANO SURGICAL, INC.

CIK 0001230355

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001230355

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:25 PM ET
Size
9.7 KB